Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/1996
12/05/1996WO1996038157A1 Inhibitor for lipid peroxide increase
12/05/1996WO1996038156A1 Use of alendronate for the prevention of osteoporosis
12/05/1996WO1996038154A1 Means for treating radiation injuries
12/05/1996WO1996038153A1 Stabilized solid dispersions of misoprostol
12/05/1996WO1996038152A1 Method for treating anorexia
12/05/1996WO1996038151A1 Method for treating cognitive dysfunction
12/05/1996WO1996038150A1 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds
12/05/1996WO1996038149A1 Eyedrops
12/05/1996WO1996038148A1 Method for preventing intervention-associated stenosis following non-bypass, invasive interventions
12/05/1996WO1996038147A1 Methods and compositions for treating infection using optically pure (s)-lomefloxacin
12/05/1996WO1996038146A1 Water soluble camptothecin analogs
12/05/1996WO1996038145A1 Methods for inhibiting vascular smooth muscle cell migration
12/05/1996WO1996038144A1 Isothiazolones
12/05/1996WO1996038143A1 The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence
12/05/1996WO1996038142A1 1h-4(5)-substituted imidazole derivatives
12/05/1996WO1996038140A1 Agents for use against parasitic protozoa
12/05/1996WO1996038139A1 Use of pyrrolidine derivatives for treating alcoholism
12/05/1996WO1996038138A1 Novel taxoids
12/05/1996WO1996038137A1 Methods for maintaining or elevating the cd-4 or cd-8 cell levels comprising the administration of conjugated linoleic acid; a new process for the manufacture of conjugated linoleic acid using lactobacillus sp
12/05/1996WO1996038136A1 Localized use of nitric oxide-adducts to prevent internal tissue damage
12/05/1996WO1996038135A1 Sorbic-acid-containing hydrogels
12/05/1996WO1996038134A1 Use of aryl substituted cyclobutyl alkyl amines for the treatment of obesity
12/05/1996WO1996038132A1 Method of altering the contents of eggs
12/05/1996WO1996038130A1 Osmotic device with delayed activation of drug delivery and complete drug release
12/05/1996WO1996038125A1 COSMETIC OR DERMATOLOGICAL COMPOSITIONS CONTAINING OLIGOMERS OR POLYMERS OF α-HYDROXYCARBOXYLIC ACIDS
12/05/1996WO1996038047A1 Fat based food products
12/05/1996WO1996034953A3 Cd16-ii variants
12/05/1996WO1996034099A3 Genetic sequences and proteins related to alzheimer's disease, and uses therefor
12/05/1996WO1996031621A3 Method for determining the responsiveness of individuals to 5-ht2 receptor modulating agents
12/05/1996DE19520275A1 Endoparasitizide Mittel Endoparasiticides means
12/05/1996DE19520237A1 Kosmetische oder dermatologische Zubereitungen, enthaltend Oligomere oder Polymere von alpha-Hydroxycarbonsäuren Cosmetic or dermatological preparations containing oligomers or polymers of alpha-hydroxycarboxylic
12/05/1996DE19519822A1 Neue antibakterielle Mittel New antibacterial agents
12/05/1996DE19519821A1 Mittel gegen parasitäre Protozoen Agents against parasitic protozoa
12/05/1996DE19518988A1 Verwendung arylsubstituierter Cyclobutylalkylamine zur Behandlung der Fettleibigkeit Use of aryl-substituted Cyclobutylalkylamine for the treatment of obesity
12/05/1996CA2762921A1 Improved formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
12/05/1996CA2223276A1 Methods for in vivo reduction of nitric oxide levels and compositions useful therefor
12/05/1996CA2222960A1 Imidazo 1,5a pyridine derived serine protease inhibitors
12/05/1996CA2222689A1 Methods and compositions for treating infection using optically pure (s)-lomefloxacin
12/05/1996CA2222609A1 Methods and uses of connective tissue growth factor as an induction agent
12/05/1996CA2222599A1 Antimicrobial cationic peptides
12/05/1996CA2222573A1 The use of alpha-1c-selective adrenoceptor agonists for the treatment of urinary incontinence
12/05/1996CA2222566A1 Hydrogels that contain sorbic acid
12/05/1996CA2222561A1 4.4-(disubstituted)cyclohexan-1-ols-monomers and related compounds
12/05/1996CA2222539A1 Agent for the treatment of radiation injuries
12/05/1996CA2222318A1 Use of alendronate for the prevention of osteoporosis
12/05/1996CA2222292A1 Methods for inhibiting vascular smooth muscle cell migration
12/05/1996CA2222179A1 Process for making heterocyclic compounds
12/05/1996CA2222147A1 Novel isoxazoline and isoxazole fibrinogen receptor antagonists
12/05/1996CA2222099A1 1h-4(5)-substituted imidazole derivatives
12/05/1996CA2222073A1 Method for treating anorexia
12/05/1996CA2222033A1 Process for making heterocyclic compounds
12/05/1996CA2221992A1 N,n-di(arylmethyl)cyclic urea derivatives as anti-coagulants
12/05/1996CA2221128A1 Hydrolysis and photocleavage of nucleic acid using a metal complex
12/05/1996CA2220040A1 Tricyclic inhibitors of matrix metalloproteinases
12/05/1996CA2219902A1 Use of 2-methyl-4-(4-methyl-1-piperazinyl)-10h-thieno¬2,3b|¬1,5|benzodiazepine for treating cognitive dysfunction
12/05/1996CA2219452A1 Method for preventing intervention-associated stenosis following non-bypass invasive interventions
12/05/1996CA2218918A1 The use of aryl-substituted cyclobutylalkylamines for treating obesity
12/05/1996CA2218253A1 Isothiazolones
12/05/1996CA2196425A1 Novel polymorphs of lesopitron dichlorohydrate and its hydrated forms, preparation methods and compositions containing them
12/05/1996CA2194397A1 (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor
12/04/1996EP0745601A1 Process for preparing 1,2,5-thiadiazole derivatives
12/04/1996EP0745600A1 Benzimidazole derivatives, their preparation and their therapeutic use
12/04/1996EP0745598A1 Piperazine, piperidine and 1,2,5,6-tetrahydropyridine derivatives, proces for their preparation and pharmaceutical compositions containing them
12/04/1996EP0745597A2 Novel melatonergic indanyl piperazines or homopiperazines
12/04/1996EP0745596A1 Heteroaromatic oxazole compounds and use thereof
12/04/1996EP0745591A1 Indanylpiperidines as melatonergic agents
12/04/1996EP0745586A1 Aryl(alkyl) propylamides, process for their preparation and pharmaceutical compositions containing them
12/04/1996EP0745584A1 Arylalkyl(thio) carboxamides compounds with affinity for melatonine receptors, processes for their preparation and pharmaceutical compositions containing them
12/04/1996EP0745583A1 Alkoxy aryl compounds with affinity to the melatonine receptors, process for their preparation and pharmaceutical compositions containing them
12/04/1996EP0745391A1 Apparatus, method and composition for preserving media in tip of solution dispenser
12/04/1996EP0745390A2 Polymeric prodrugs for beta-lactamase and uses thereof
12/04/1996EP0745389A1 Composition for topical application
12/04/1996EP0745384A2 Methods for inhibiting vascular smooth muscle cell migration
12/04/1996EP0745380A2 Tobacco substitute
12/04/1996EP0745375A1 Skin care compositions containing dimethyl imidazolidinone and retinol or retinyl ester
12/04/1996EP0745330A1 Anti-regurgitation infant formula
12/04/1996EP0745324A1 Stable micro-emulsions of certain 3-isothiazolone compounds
12/04/1996EP0745136A1 B7-1-specific ligands, and their use for the induction of t cell anergy
12/04/1996EP0745131A1 Targeting gene therapy
12/04/1996EP0745127A1 Control of marek's disease by the inhibition of latency and tumor cell development
12/04/1996EP0745122A1 Galanin receptor, nucleic acids, transformed cells and uses thereof
12/04/1996EP0745121A1 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
12/04/1996EP0745092A1 Peptide inhibitors of urokinase receptor activity
12/04/1996EP0745089A1 Antiparasitic agents
12/04/1996EP0745088A1 1-(2'-hydroxy- and 2'-sulphatoalkyl)glycosides
12/04/1996EP0745087A1 Novel cytotoxic macrolides, their isolation from a marine sponge and their use as antitumor agents
12/04/1996EP0745086A1 Tricyclic spiropiperidines
12/04/1996EP0745085A1 Texaphyrin metal complexes having improved functionalization
12/04/1996EP0745083A1 2-HETEROARYL-5,11-DIHYDRO-6H-DIPYRIDO [3,2-b:2',3'-e][1,4]DIAZEPINES AND THEIR USE IN THE PREVENTION OR TREATMENT OF HIV INFECTION
12/04/1996EP0745081A1 Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
12/04/1996EP0745080A1 Novel mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase and ace
12/04/1996EP0745079A1 Phenylpyrrole derivatives and their use as dopamine d3 antagonists
12/04/1996EP0745078A1 Enantiomerically pure(-)-liarozole
12/04/1996EP0745077A1 Enantiomerically pure (+)-liarozole
12/04/1996EP0745075A1 6-substituted mycophenolic and derivatives with immunosuppressive activity
12/04/1996EP0745074A1 4-amino derivatives of mycophenolic acid with immunosuppressant activity
12/04/1996EP0745073A1 5-substituted derivatives of mycophenolic acid
12/04/1996EP0745072A1 4-amino derivatives of 5-substituted mycophenolic acid
12/04/1996EP0745071A1 4-amino 6-substituted mycophenolic acid and derivatives with immunosuppressive activity
12/04/1996EP0745070A1 Pharmaceutical piperazine compounds
1 ... 6853 6854 6855 6856 6857 6858 6859 6860 6861 6862 6863 6864 6865 6866 6867 6868 6869 6870 6871 6872 6873 ... 7860